$136 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 35 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 44.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $19,161,380 | +70.4% | 290,500 | +33.6% | 14.12% | +104.0% |
| AADI BIOSCIENCES INC | $13,389,670 | -31.8% | 1,849,402 | 0.0% | 9.86% | -18.3% | ||
| TERN | Sell | TERNS PHARMACEUTICALS INC | $13,015,819 | +16.2% | 1,099,309 | -0.1% | 9.59% | +39.2% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC. COMMON STOCK | $7,660,520 | +20.4% | 878,500 | -13.4% | 5.64% | +44.1% |
| Sell | VENTYX BIOSCIENCES INC | $6,984,750 | -7.6% | 208,500 | -28.2% | 5.15% | +10.6% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,969,600 | -15.6% | 330,000 | +1.7% | 5.13% | +1.0% |
| KURA | Buy | KURA ONCOLOGY INC. COMMON STOCK | $6,913,093 | +11.1% | 565,257 | +12.7% | 5.09% | +33.0% |
| ISEE | Sell | IVERIC BIO INC | $6,824,565 | -11.6% | 280,500 | -22.2% | 5.03% | +5.9% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $5,263,060 | -42.6% | 23,500 | -28.8% | 3.88% | -31.3% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $5,104,740 | +0.3% | 298,000 | +14.6% | 3.76% | +20.1% |
| BLU | BELLUS HEALTH INC | $4,554,000 | -12.4% | 632,500 | 0.0% | 3.36% | +4.9% | |
| PCVX | Sell | VAXCYTE INC | $4,516,340 | -34.8% | 120,500 | -16.6% | 3.33% | -22.0% |
| SRPT | Sell | SAREPTA TEHRAPEUTICS INC | $4,516,689 | -48.4% | 32,770 | -51.5% | 3.33% | -38.2% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC | $4,371,570 | -14.7% | 121,500 | +5.7% | 3.22% | +2.1% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $4,273,920 | -63.1% | 168,000 | -57.6% | 3.15% | -55.8% |
| New | IVERIC BIO INCcall | $3,649,500 | – | 1,500 | +100.0% | 2.69% | – | |
| New | CELLDEX THERAPEUTICS INCput | $3,598,000 | – | 1,000 | +100.0% | 2.65% | – | |
| ARGX | Buy | ARGEN SEsponsored adr | $3,574,533 | +85.0% | 9,594 | +88.1% | 2.63% | +121.4% |
| GHRS | GH RESEARCH PLCordinary shares | $1,943,568 | -17.8% | 243,250 | 0.0% | 1.43% | -1.6% | |
| FDMT | New | 4D MOLECULAR THERAPEUTICS INC | $1,800,704 | – | 104,753 | +100.0% | 1.33% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS | $985,686 | -75.5% | 121,840 | -52.2% | 0.73% | -70.6% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $938,734 | -4.4% | 153,639 | 0.0% | 0.69% | +14.6% | |
| ALKS | New | ALKERMES PLC | $893,313 | – | 31,689 | +100.0% | 0.66% | – |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $891,984 | -16.0% | 303,396 | 0.0% | 0.66% | +0.6% | |
| PMVP | PMV PHARMACEUTICALS INC | $736,827 | -45.2% | 154,471 | 0.0% | 0.54% | -34.3% | |
| RZLT | Sell | REZOLUTE INC | $703,112 | -19.1% | 366,204 | -12.8% | 0.52% | -3.2% |
| New | ENLIVEN THERAPEUTICS INC | $678,440 | – | 30,979 | +100.0% | 0.50% | – | |
| HZNP | HORIZON THERAPEUTICS PLC | $654,840 | -4.1% | 6,000 | 0.0% | 0.48% | +14.8% | |
| SVRA | New | SAVARA INC | $388,110 | – | 199,031 | +100.0% | 0.29% | – |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $246,600 | -95.6% | 60,000 | -93.7% | 0.18% | -94.7% |
| VKTX | New | VIKING THERAPEUTICS INC | $233,100 | – | 14,000 | +100.0% | 0.17% | – |
| KROS | Sell | KEROS THERAPEUTICS INC | $152,653 | -96.0% | 3,575 | -95.5% | 0.11% | -95.3% |
| New | HILLEVAX INC | $110,156 | – | 6,664 | +100.0% | 0.08% | – | |
| KNTE | KINNATE BIOPHARMA INC | $31,250 | +2.5% | 5,000 | 0.0% | 0.02% | +21.1% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/2027 | $10,900 | -17.0% | 90,832 | 0.0% | 0.01% | 0.0% | |
| IMRA | Exit | IMARA INC | $0 | – | -44,503 | -100.0% | -0.11% | – |
| PRTA | Exit | PROTHENA CORPORATION PLC | $0 | – | -9,300 | -100.0% | -0.34% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -669,158 | -100.0% | -0.55% | – | |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -93,500 | -100.0% | -0.60% | – | |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -185,000 | -100.0% | -0.83% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS INC | $0 | – | -41,029 | -100.0% | -1.02% | – |
| BCAB | Exit | BIOATLA INC | $0 | – | -500,000 | -100.0% | -2.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.